The analyst expressed cautious optimism about Lucid’s recently signed multi-year supply agreement with Graphite One.

Sarepta Therapeutics Inc. plummeted after reporting a second patient died of acute liver failure while being treated with its gene therapy for a rare muscle disorder.

In accordance with Rule 29 of the AIM Rules for Companies (“the AIM Rules”), Caledonia Mining Corporation Plc (“Caledonia” or “the ...

Critical Metals Corp has received a letter of interest from the U.S. Export-Import Bank (EXIM) for a loan worth up to $120 ...

Docebo Inc. (NASDAQ:DCBO) is one of the 10 Best Small-Cap Growth Stocks to Buy According to Analysts. On June 9, analyst Yi ...

Former President Trump unveils TrumpCard.gov. The site is live but the program awaits federal approval. WASHINGTON, D.C. – ...

The analysts at Cantor Fitzgerald have raised their 12-month price target for Coinbase (Nasdaq: COIN) from $253 to $292.

Eli Lilly's experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an ...

While Cantor analysts also said AMD has cemented "itself as a clear second source for GPUs" against Nvidia, this year will be "more of a stopgap year," and the chip maker will see "more meaningful ...

Cantor Fitzgerald issued a research note earlier this week, maintaining its overweight rating on the stock and issuing a $13 price target. Analyst Andres Sheppard said the company recently conducted a ...

AbbVie’s price target got a fresh boost as Citigroup raised it to $205, joining a chorus of analysts expressing optimism.